{
  "experiment_id": "b8530c98e725e1fd4a8f89ba8afa98a2",
  "task_name": "broadening_of_narrow_synonyms",
  "task_hash": "a2c885aa2a82bb5b150f213062bbeb89",
  "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
  "system_instructions": "### Temperature\n\n1.0",
  "temperature": 1.0,
  "thinking": false,
  "tools": [],
  "timestamp": "2025-11-15T05:26:57.183279",
  "task_result": {
    "task_name": "broadening_of_narrow_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 microdeletion syndrome",
          "assay": "clinical whole-exome sequencing",
          "tumorType": "Plexiform neurofibroma (morphologic abnormality)"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"Neurofibromatosis type 1 microdeletion syndrome\" \u2192 \"Neurofibromatosis type 1\"\n   - Broadened the narrow specific subtype to the standard, more general diagnosis term from the controlled vocabulary.\n\n2. **assay**: \"clinical whole-exome sequencing\" \u2192 \"whole exome sequencing\"\n   - Removed the qualifier \"clinical\" to match the exact controlled terminology value.\n\n3. **tumorType**: \"Plexiform neurofibroma (morphologic abnormality)\" \u2192 \"Plexiform Neurofibroma\"\n   - Removed the descriptor \"(morphologic abnormality)\" and standardized capitalization to match the exact controlled terminology value.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3016,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 230
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01MQSR2LiSXi6phtSozz3oAK",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"Neurofibromatosis type 1 microdeletion syndrome\" \u2192 \"Neurofibromatosis type 1\"\n   - Broadened the narrow specific subtype to the standard, more general diagnosis term from the controlled vocabulary.\n\n2. **assay**: \"clinical whole-exome sequencing\" \u2192 \"whole exome sequencing\"\n   - Removed the qualifier \"clinical\" to match the exact controlled terminology value.\n\n3. **tumorType**: \"Plexiform neurofibroma (morphologic abnormality)\" \u2192 \"Plexiform Neurofibroma\"\n   - Removed the descriptor \"(morphologic abnormality)\" and standardized capitalization to match the exact controlled terminology value."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3016,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 230
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3016,
          "output_tokens": 230,
          "total_tokens": 3246
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with optic pathway glioma",
          "assay": "Illumina whole exome sequencing ",
          "tumorType": "malignant triton tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: Broadened from \"Neurofibromatosis type 1 with optic pathway glioma\" to \"Neurofibromatosis type 1\" (the optic pathway glioma is a tumor manifestation, not part of the diagnosis enum; the primary diagnosis is NF1)\n\n2. **assay**: Broadened from \"Illumina whole exome sequencing\" to \"whole exome sequencing\" (removed vendor-specific prefix to use standard controlled terminology)\n\n3. **tumorType**: Broadened from \"malignant triton tumor\" to \"Malignant Peripheral Nerve Sheath Tumor\" (malignant triton tumor is a specific subtype of MPNST; using the broader standard term with correct capitalization from the schema)",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3011,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 249
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01HXuDJDYrtotyu75nCjKt4B",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: Broadened from \"Neurofibromatosis type 1 with optic pathway glioma\" to \"Neurofibromatosis type 1\" (the optic pathway glioma is a tumor manifestation, not part of the diagnosis enum; the primary diagnosis is NF1)\n\n2. **assay**: Broadened from \"Illumina whole exome sequencing\" to \"whole exome sequencing\" (removed vendor-specific prefix to use standard controlled terminology)\n\n3. **tumorType**: Broadened from \"malignant triton tumor\" to \"Malignant Peripheral Nerve Sheath Tumor\" (malignant triton tumor is a specific subtype of MPNST; using the broader standard term with correct capitalization from the schema)"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3011,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 249
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3011,
          "output_tokens": 249,
          "total_tokens": 3260
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Watson Syndrome",
          "assay": "MGI whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"Watson Syndrome\" \u2192 \"Noonan Syndrome\"\n   - Watson Syndrome is a specific form of Noonan Syndrome, which is the broader, standard term in the controlled vocabulary.\n\n2. **assay**: \"MGI whole genome sequencing\" \u2192 \"whole genome sequencing\"\n   - \"MGI\" is a specific vendor/platform (MGI Tech) that narrows the term. The broader, standard term is \"whole genome sequencing\".\n\n3. **tumorType**: \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - \"with Mesenchymal Differentiation\" is a specific histological descriptor that narrows the term. The broader, standard term matches the exact controlled vocabulary value.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3010,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 257
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01Ek7y7X9ea8pH6dvRqcok2Q",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"Watson Syndrome\" \u2192 \"Noonan Syndrome\"\n   - Watson Syndrome is a specific form of Noonan Syndrome, which is the broader, standard term in the controlled vocabulary.\n\n2. **assay**: \"MGI whole genome sequencing\" \u2192 \"whole genome sequencing\"\n   - \"MGI\" is a specific vendor/platform (MGI Tech) that narrows the term. The broader, standard term is \"whole genome sequencing\".\n\n3. **tumorType**: \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - \"with Mesenchymal Differentiation\" is a specific histological descriptor that narrows the term. The broader, standard term matches the exact controlled vocabulary value."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3010,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 257
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3010,
          "output_tokens": 257,
          "total_tokens": 3267
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurofibromatosis, familial spinal",
          "assay": "open MRI",
          "tumorType": "unknown - no information available"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"neurofibromatosis, familial spinal\" \u2192 \"Neurofibromatosis type 1\" \n   - The narrow term describing familial spinal neurofibromatosis is broadened to the standard controlled terminology for the general condition.\n\n2. **assay**: \"open MRI\" \u2192 \"conventional MRI\"\n   - \"Open MRI\" is a specific type of MRI scanner; the broader standard term in the schema is \"conventional MRI\".\n\n3. **tumorType**: \"unknown - no information available\" \u2192 \"Unknown\"\n   - Matched to the exact controlled terminology value from the enum.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 2998,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 200
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01AAGhd64T5tFv5nLSzmHbqu",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"neurofibromatosis, familial spinal\" \u2192 \"Neurofibromatosis type 1\" \n   - The narrow term describing familial spinal neurofibromatosis is broadened to the standard controlled terminology for the general condition.\n\n2. **assay**: \"open MRI\" \u2192 \"conventional MRI\"\n   - \"Open MRI\" is a specific type of MRI scanner; the broader standard term in the schema is \"conventional MRI\".\n\n3. **tumorType**: \"unknown - no information available\" \u2192 \"Unknown\"\n   - Matched to the exact controlled terminology value from the enum."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 2998,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 200
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2998,
          "output_tokens": 200,
          "total_tokens": 3198
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry of skin",
          "tumorType": "Cutaneous storiform neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: No change needed - \"Not Applicable\" is already in the controlled terminology.\n\n2. **assay**: Changed \"immunohistochemistry of skin\" to \"immunohistochemistry\" - the narrower term specifying the tissue type has been broadened to the standard controlled term that represents the general assay method.\n\n3. **tumorType**: Changed \"Cutaneous storiform neurofibroma\" to \"Cutaneous Neurofibroma\" - the descriptor \"storiform\" (a morphological variant) has been removed to use the exact controlled terminology value. \"Cutaneous Neurofibroma\" is the appropriate broader term from the schema.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 2998,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 204
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01T5tL5uwhfMGZoELtXuZdjF",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: No change needed - \"Not Applicable\" is already in the controlled terminology.\n\n2. **assay**: Changed \"immunohistochemistry of skin\" to \"immunohistochemistry\" - the narrower term specifying the tissue type has been broadened to the standard controlled term that represents the general assay method.\n\n3. **tumorType**: Changed \"Cutaneous storiform neurofibroma\" to \"Cutaneous Neurofibroma\" - the descriptor \"storiform\" (a morphological variant) has been removed to use the exact controlled terminology value. \"Cutaneous Neurofibroma\" is the appropriate broader term from the schema."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 2998,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 204
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2998,
          "output_tokens": 204,
          "total_tokens": 3202
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "chromosome 17q11.2 deletion syndrome, 1.4Mb",
          "assay": "cell viability assay using Annexin V staining",
          "tumorType": "Pedunculated Cutaneous Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" \u2192 \"Neurofibromatosis type 1\"\n   - The 17q11.2 deletion is the genetic basis of NF1; broadened to the standard clinical diagnosis term from the enum.\n\n2. **assay**: \"cell viability assay using Annexin V staining\" \u2192 \"cell viability assay\"\n   - Removed the specific methodology detail (Annexin V staining) to use the broader, standard assay term from the enum.\n\n3. **tumorType**: \"Pedunculated Cutaneous Neurofibroma\" \u2192 \"Cutaneous Neurofibroma\"\n   - Removed the morphological descriptor (\"Pedunculated\") to use the standard enum value. \"Cutaneous Neurofibroma\" is the appropriate controlled term that encompasses cutaneous neurofibromas regardless of specific growth patterns.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3020,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 279
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01CNFsiyV7c7E9SHfo6BKaEs",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" \u2192 \"Neurofibromatosis type 1\"\n   - The 17q11.2 deletion is the genetic basis of NF1; broadened to the standard clinical diagnosis term from the enum.\n\n2. **assay**: \"cell viability assay using Annexin V staining\" \u2192 \"cell viability assay\"\n   - Removed the specific methodology detail (Annexin V staining) to use the broader, standard assay term from the enum.\n\n3. **tumorType**: \"Pedunculated Cutaneous Neurofibroma\" \u2192 \"Cutaneous Neurofibroma\"\n   - Removed the morphological descriptor (\"Pedunculated\") to use the standard enum value. \"Cutaneous Neurofibroma\" is the appropriate controlled term that encompasses cutaneous neurofibromas regardless of specific growth patterns."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3020,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 279
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3020,
          "output_tokens": 279,
          "total_tokens": 3299
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with scoliosis",
          "assay": "anti-tag immunocytochemistry",
          "tumorType": "sessile cutaneous neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Removed the secondary condition \"with scoliosis\" to match the controlled terminology. The diagnosis is now the primary condition \"Neurofibromatosis type 1\" (exact match from enum).\n\n2. **assay**: Broadened \"anti-tag immunocytochemistry\" to \"immunocytochemistry\" (exact match from enum). The \"anti-tag\" descriptor is a technique detail that narrows the general assay method.\n\n3. **tumorType**: Broadened \"sessile cutaneous neurofibroma\" to \"Cutaneous Neurofibroma\" (exact match from enum). The \"sessile\" descriptor is a morphological specification that narrows the general tumor type classification.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3011,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 224
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_017cbPqM3z6n9E3MJYfEVpB1",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Removed the secondary condition \"with scoliosis\" to match the controlled terminology. The diagnosis is now the primary condition \"Neurofibromatosis type 1\" (exact match from enum).\n\n2. **assay**: Broadened \"anti-tag immunocytochemistry\" to \"immunocytochemistry\" (exact match from enum). The \"anti-tag\" descriptor is a technique detail that narrows the general assay method.\n\n3. **tumorType**: Broadened \"sessile cutaneous neurofibroma\" to \"Cutaneous Neurofibroma\" (exact match from enum). The \"sessile\" descriptor is a morphological specification that narrows the general tumor type classification."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3011,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 224
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3011,
          "output_tokens": 224,
          "total_tokens": 3235
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "neurofibromatosis, peripheral type",
          "assay": "wide bore MRI",
          "tumorType": "no clear diagnosis"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Not Applicable\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"neurofibromatosis, peripheral type\" \u2192 \"Neurofibromatosis type 1\"\n   - Broadened from a specific descriptor to the standard controlled terminology for the peripheral form of neurofibromatosis\n\n2. **assay**: \"wide bore MRI\" \u2192 \"conventional MRI\"\n   - Broadened from a technical specification (wide bore) to the standard general category of MRI imaging method\n\n3. **tumorType**: \"no clear diagnosis\" \u2192 \"Not Applicable\"\n   - Corrected to the appropriate controlled value indicating no tumor type is applicable, rather than using a descriptive phrase",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 2995,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 200
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01HxPQ3Hs3XFrntPDVnPEhFL",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Not Applicable\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"neurofibromatosis, peripheral type\" \u2192 \"Neurofibromatosis type 1\"\n   - Broadened from a specific descriptor to the standard controlled terminology for the peripheral form of neurofibromatosis\n\n2. **assay**: \"wide bore MRI\" \u2192 \"conventional MRI\"\n   - Broadened from a technical specification (wide bore) to the standard general category of MRI imaging method\n\n3. **tumorType**: \"no clear diagnosis\" \u2192 \"Not Applicable\"\n   - Corrected to the appropriate controlled value indicating no tumor type is applicable, rather than using a descriptive phrase"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 2995,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 200
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2995,
          "output_tokens": 200,
          "total_tokens": 3195
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "acoustic neurofibromatosis",
          "assay": "RNA-seq with ribosomal RNA depletion",
          "tumorType": "Acoustic neuroma of left vestibular nerve"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Vestibular Schwannoma\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"acoustic neurofibromatosis\" \u2192 \"Vestibular Schwannoma\"\n   - Acoustic neuroma (schwannoma) of the vestibular nerve is the standard term for this condition.\n\n2. **assay**: \"RNA-seq with ribosomal RNA depletion\" \u2192 \"RNA-seq\"\n   - The technical detail about rRNA depletion is a methodological variation; the broader standard assay term is \"RNA-seq\" from the controlled vocabulary.\n\n3. **tumorType**: \"Acoustic neuroma of left vestibular nerve\" \u2192 \"Schwannoma\"\n   - Acoustic neuroma is a narrow synonym for vestibular schwannoma. The standard controlled term is \"Schwannoma\" (laterality and anatomical specificity are typically captured in other metadata fields, not in the tumorType enum).",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3008,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 251
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01NBZwy1tqG7vffhtfMem9Zp",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Vestibular Schwannoma\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"acoustic neurofibromatosis\" \u2192 \"Vestibular Schwannoma\"\n   - Acoustic neuroma (schwannoma) of the vestibular nerve is the standard term for this condition.\n\n2. **assay**: \"RNA-seq with ribosomal RNA depletion\" \u2192 \"RNA-seq\"\n   - The technical detail about rRNA depletion is a methodological variation; the broader standard assay term is \"RNA-seq\" from the controlled vocabulary.\n\n3. **tumorType**: \"Acoustic neuroma of left vestibular nerve\" \u2192 \"Schwannoma\"\n   - Acoustic neuroma is a narrow synonym for vestibular schwannoma. The standard controlled term is \"Schwannoma\" (laterality and anatomical specificity are typically captured in other metadata fields, not in the tumorType enum)."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3008,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 251
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 3008,
          "output_tokens": 251,
          "total_tokens": 3259
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "neurofibromatosis type 1 due to NF1 mutation or intragenic deletion",
          "assay": "CellTiter-Glo\u00ae 3D Cell Viability Assay",
          "tumorType": "Epithelioid Malignant Peripheral Nerve Sheath Tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\" to the standard controlled term \"Neurofibromatosis type 1\" (removed the mechanistic detail about the mutation/deletion, which is appropriately narrower than the diagnosis itself).\n\n2. **assay**: Broadened \"CellTiter-Glo\u00ae 3D Cell Viability Assay\" to the standard controlled term \"cell viability assay\" (the specific commercial product name is a narrow synonym for the general assay type).\n\n3. **tumorType**: Broadened \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\" to \"Malignant Peripheral Nerve Sheath Tumor\" (removed the histologic subtype specification \"epithelioid,\" which is narrower than the general tumor classification available in the schema).",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3041,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 276
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01M6JHvuvjmkXjjqxBH7Vg2v",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\" to the standard controlled term \"Neurofibromatosis type 1\" (removed the mechanistic detail about the mutation/deletion, which is appropriately narrower than the diagnosis itself).\n\n2. **assay**: Broadened \"CellTiter-Glo\u00ae 3D Cell Viability Assay\" to the standard controlled term \"cell viability assay\" (the specific commercial product name is a narrow synonym for the general assay type).\n\n3. **tumorType**: Broadened \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\" to \"Malignant Peripheral Nerve Sheath Tumor\" (removed the histologic subtype specification \"epithelioid,\" which is narrower than the general tumor classification available in the schema)."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3041,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 276
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3041,
          "output_tokens": 276,
          "total_tokens": 3317
        },
        "tool_calls": [],
        "tool_execution_history": []
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.8333333333333333,
      "min_score": 0.3333333333333333,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 29.07901930809021,
    "token_usage": {
      "input_tokens": 30108,
      "output_tokens": 2370,
      "total_tokens": 32478
    }
  }
}